Table 5 Multivariate analysis of risk factors for VRE nosocomial rectal colonization in hematological patients
| Â | OR | 95% CI | p-value | Â |
|---|---|---|---|---|
Any use of vancomycin | 3.5 | (1.15–10.87) | 0.027 |  |
Use of third generation cephalosporins | 7.7 | (0.87–67.99) | 0.067 |  |
Bone marrow transplant | 2.3 | (0.65–8.08) | 0.200 |  |
Altered bowel habits | 3.1 | (1.07–8.94) | 0.036 |  |
Hospitalization in the previous 6 months | 2.3 | (0.93–5.43) | 0.170 |  |